Watching the Watchdog: How Does ICER Determine ‘Fair’ Prices for Drugs?

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $149 per year, you reward quality independent biotech reporting, and encourage more.

You may also like

Getting to Precision Medicine for I-O Combinations – It’s Even More Complicated
State Laws Zero in On Rising Drug Costs
Getting to Precision Medicine – It’s Complicated
Parting Thoughts from Genzyme CEO David Meeker